SCHEMBL1129034

SCHEMBL1129034

Cc1ccc2nc(C(C)(C)Cl)[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
KMT2A Q03164 2/20 0.51
POLB P06746 1/20 0.51
HSD17B10 Q99714 2/20 0.51
GAA P10253 2/20 0.51
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
USP2 O75604 1/20 0.50
HTT P42858 1/20 0.50
CYP1A2 P05177 1/20 0.49
PIN1 Q13526 1/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KCNH2 Q12809 1/20 0.47
SCN10A Q9Y5Y9 1/20 0.47
TP53 P04637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
ADORA2A P29274 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129051 0.86 KMT2A (0.40) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL3269719 0.86 ALDH1A1 (0.58) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL436153 0.81 ALDH1A1 (0.63) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL827359 0.74 KMT2A (0.58) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL4349193 0.74 KMT2A (0.41) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL266609 0.74 ALDH1A1 (0.66) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL29727934 0.74 ALDH1A1 (0.66) KDM4EKMT2APOLBHSD17B10GAA
SCHEMBL18462380 0.73 ALDH1A1 (0.52) KMT2APOLBALDH1A1HPGDUSP2
SCHEMBL14601538 0.73 KMT2A (0.43) KDM4EKMT2APOLBALDH1A1HPGD
SCHEMBL8741313 0.73 KMT2A (0.56) KDM4EKMT2APOLBHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282762-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2011-02-16 EP disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed